SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Nasus Pharma Ltd
@NSRX_InsiderForm 4 Filing: Teleman Dan Benjamin Buys $20,305 of $NSRX
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Nasus Pharma Ltd
Ticker: $NSRX
Transaction Value
$20,305
Price/Share: $3.10
transaction date
2026-06-17
Shares: 6,550
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Teleman Dan Benjamin, holds the title of Chief Executive Officer at Nasus Pharma Ltd.
On 2026-06-17, the insider transacted 6,550 shares.The shares were transacted at a weighted average price of $3.10 per share, resulting in a total market-relevant value of $20,305.
Executive Summary Summary
Teleman Dan Benjamin (Chief Executive Officer) bought $20K of $NSRX
Post-Transaction Position: 163,541 shares
SEC Accession No: 0001493152-26-029484 (CIK: 2122500)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.